A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: family member (384), relative (245)

Clarithromycin-Dexamethasone_40_Pomalidomide

Description
Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (40)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (40)-Pomalidomide Ind
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-40-Pomalidomide.pdf

Clarithromycin-Dexamethasone_20_Pomalidomide

Description
Chemotherapy Protocol Myeloma Clarithromycin-Dexamethasone (20)-Pomalidomide Regimen • Myeloma – Clarithromycin-Dexamethasone (20)-Pomalidom
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Clarithromycin-Dexamethasone-20-Pomalidomide.pdf

Hydration Pilots application and support pack process

Description
January Classification: Official Hydration Pilots: Application support pack & process Hydration Pilots: application support pack an
Url
/Media/Southampton-Clinical-Research/Grants/Download/Hydration-Pilots-application-and-support-pack-process.docx

Fulvestrant-Ribociclib

Description
Chemotherapy Protocol Breast Cancer Fulvestrant-Ribociclib Regimen • Breast Cancer – Fulvestrant-Ribociclib Indication • Fulvestrant and ribocicl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Fulvestrant-Ribociclib.pdf

VR-RituximabVenetoclax Cycle_2 Onwards

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) (Cycle 2 onwards) Regimen • CLL – VR Rituximab Venetocl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclax-Cycle-2-Onwards.pdf

VenetoclaxLow

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (low risk) Funding may be required for this regimen. Regimen • CLL – Venetocl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxLow.pdf

IdelalisibRituximab

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Idelalisib-Rituximab Regimen • CLL – Idelalisib-Rituximab Indication • Chronic lym
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/IdelalisibRituximab.pdf

Chlorambucil_7_Rituximab_Split

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (7 day)-Rituximab (Split) Regimen • CLL – Chlorambucil (7 day)-Rituxi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7-Rituximab-Split.pdf

Chlorambucil_2_Obinutuzumab

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (2 day)-Obinutuzumab (6 cycles) Regimen • CLL – Chlorambucil (2 day)-Obinutuzumab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-2-Obinutuzumab.pdf

Chlorambucil_14_Rituximab_Split

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (14 day)-Rituximab (Split) Regimen • CLL – Chlorambucil (14 day)-Ritu
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14-Rituximab-Split.pdf
281 to 290 of 312
Previous … 27 28 29 30 31 … Next